The global cysteine market size reached US$ 387.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 516.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028.
Cysteine is a non-essential sulfur-based amino acid used for protein synthesis, detoxification and numerous metabolic functions. It is biosynthesized through beta-keratin in nails, skin and hair and it promotes the stability of proteins by building di-sulfide bridges. It also increases collagen production and improves skin elasticity and texture. It is a rich source of antioxidants and aids in reducing inflammation, cell damage and reversing the effects of aging. Cysteine metabolizes essential biochemicals, such as coenzyme A, heparin and biotin and can also aid in minimizing the risks of developing cancer, diabetes and cardiovascular ailments. As a result, it is widely used as a reducing agent in the manufacturing of pharmaceuticals, cosmetics, personal care products, food supplements and flavor enhancers.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Cysteine is widely used for total parenteral nutrition and as an antidote for acetaminophen overdose. It also aids in the treatment of metabolic disorders and malabsorption syndromes. Moreover, the widespread product adoption in the food and beverage industry is providing a thrust to the market growth. Cysteine is used as a dough conditioner and strengthener to break the disulfide bonds of gluten and lower the viscosity of the dough in bakery products. In line with this, the increasing product utilization in the manufacturing of cosmetics and personal care products is also contributing to the market growth. Cysteine acts as an anti-static, conditioning and waving agent and fragrance ingredient in hair care products. Other factors, including extensive research and development (R&D) activities, along with the increasing expenditure capacities of the consumers, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cysteine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on production process, application and end use industry.
Breakup by Production Process:
Breakup by Application:
Human Insulin Production
Breakup by End-Use Industry:
Food and Dietary Supplement
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.) and Wuxi Bikang Bioengineering Co. Ltd.
Base Year of the Analysis
Production Process, Application, End Use Industry, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global cysteine market was valued at US$ 387.5 Million in 2022.
We expect the global cysteine market to exhibit a CAGR of 4.6% during 2023-2028.
The rising utilization of cysteine as a reducing agent in the manufacturing of pharmaceuticals, cosmetics, personal care products, food supplements, etc., is primarily driving the global cysteine market.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations, resulting in the temporary closure of numerous end-use industries for cysteine.
Based on the production process, the global cysteine market can be segmented into natural and synthetic. Currently, synthetic holds the majority of the total market share.
Based on the application, the global cysteine market has been divided into conditioner, flavor enhancer, reducing agent, human insulin production, and others. Among these, flavor enhancer currently exhibits a clear dominance in the market.
Based on the end-use industry, the global cysteine market can be categorized into food and dietary supplement, pharmaceutical, cosmetic, animal feed, and others. Currently, food and dietary supplement accounts for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.
Some of the major players in the global cysteine market include Ajinomoto Co. Inc., CJ CheilJedang Corp., Merck KGaA, Nippon Rika Co. Ltd, Shanghai Cosroma Biotech Co. Ltd, Shine Star (Hubei) Biological Engineering Co. Ltd., Wacker Chemie AG, Wuhan Grand Hoyo Co. Ltd. (Grand Pharma (China) Co. Ltd.), and Wuxi Bikang Bioengineering Co. Ltd.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.